Hashimoto's thyroiditis one of the most prevalent and common autoimmune disease. The individual suffering from Hashimoto’s thyroiditis has his/her own immune system attack the thyroid gland leading to chronic destruction of the thyroid gland. This causes inflammation and reduces the secretion of thyroid hormones. Insufficient thyroid hormones result in hypothyroidism.
This report contains market size and forecasts of Hashimotos Thyroiditis Drug in Global, including the following market information:
Global Hashimotos Thyroiditis Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hashimotos Thyroiditis Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Capsule Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hashimotos Thyroiditis Drug include LGM Pharma, Merck, Sichuan Hairong Pharmaceutical, Jerome Stevens Pharmaceuticals, Pfizer, Manus Aktteva, Shenzhen Zhonglian Pharmaceutical, Menarini and Novartis. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hashimotos Thyroiditis Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hashimotos Thyroiditis Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hashimotos Thyroiditis Drug Market Segment Percentages, by Type, 2021 (%)
Capsule
Tablet
Powder
Global Hashimotos Thyroiditis Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hashimotos Thyroiditis Drug Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Hashimotos Thyroiditis Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hashimotos Thyroiditis Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hashimotos Thyroiditis Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hashimotos Thyroiditis Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
LGM Pharma
Merck
Sichuan Hairong Pharmaceutical
Jerome Stevens Pharmaceuticals
Pfizer
Manus Aktteva
Shenzhen Zhonglian Pharmaceutical
Menarini
Novartis